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Abstract
Background: The Duffy antigen receptor for chemokines (DARC) shows high affinity binding to multiple inflammatory CC
and CXC chemokines and is expressed by erythrocytes and endothelial cells. Recent evidence suggests that endothelial
DARC facilitates chemokine transcytosis to promote neutrophil recruitment. However, the mechanism of chemokine
endocytosis by DARC remains unclear.
Methodology/Principal Findings: We investigated the role of several endocytic pathways in DARC-mediated ligand
internalization. Here we report that, although DARC co-localizes with caveolin-1 in endothelial cells, caveolin-1 is
dispensable for DARC-mediated
125I-CXCL1 endocytosis as knockdown of caveolin-1 failed to inhibit ligand internalization.
125I-CXCL1 endocytosis by DARC was also independent of clathrin and flotillin-1 but required cholesterol and was, in part,
inhibited by silencing Dynamin II expression.
125I-CXCL1 endocytosis was inhibited by amiloride, cytochalasin D, and the
PKC inhibitor Go ¨6976 whereas Platelet Derived Growth Factor (PDGF) enhanced ligand internalization through DARC. The
majority of DARC-ligand interactions occurred on the endothelial surface, with DARC identified along plasma membrane
extensions with the appearance of ruffles, supporting the concept that DARC provides a high affinity scaffolding function
for surface retention of chemokines on endothelial cells.
Conclusions/Significance: These results show DARC-mediated chemokine endocytosis occurs through a macropinocytosis-
like process in endothelial cells and caveolin-1 is dispensable for CXCL1 internalization.
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Introduction
The malarial parasite receptor and minor blood group antigen,
Duffy, is a chemokine binding protein expressed on erythrocytes
and the surface of post-capillary venular endothelial cells [1,2,3].
Unlike other heptahelical receptors, Duffy Antigen Receptor for
Chemokines (DARC), lacks a G-coupling protein motif and
therefore does not participate in G-protein mediated signaling [4].
As ligation of erythrocyte Duffy by chemokines renders chemo-
kines inaccessible to circulating neutrophils, the concept of DARC
as a chemokine sink was established [1]. However, the role of
DARC appears to be more expansive, as we and others have
established that both erythrocyte and endothelial DARC can
modulate the inflammatory response and chemokine-mediated
neutrophil recruitment during inflammatory states [1,5,6,7,8,9].
The findings of enhanced expression of DARC on post capillary
venular endothelium and capillaries of the lungs during inflammatory
states further support DARC’s role in inflammation [10]. We have
previously shown that endothelial DARC is up-regulated in the
capillaries of human lungs during suppurative pneumonia, a
condition characterized by intense neutrophilic inflammation [10].
Furthermore, we have also shown that DARC facilitates the
movement of radiolabeled
125I- C X C L 1 / G R O - a across an endo-
thelial monolayer and augments neutrophil recruitment to inflam-
m a t o r ys i t e s[ 5 ] .C o n s i s t e n tw i t ht h i sf i n d i n g ,o t h e r sh a v es h o w nt h a t
Duffy antigen mediates chemokine endocytosis [8]. Interestingly,
once internalized by DARC, chemokine was not degraded but
transcytosed and retained on the apical surface of the endothelium,
where it can be presented to circulating neutrophils and thus
participate in neutrophil recruitment during inflammatory states [8].
In endothelial cells, DARC has been detected within membrane
invaginations that have the appearance of caveolae [11]. CXCL8,
a known Duffy ligand, has been shown to localize within caveolar
vesicles following endocytosis [12]. Recent studies have also
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e29624demonstrated that DARC mediates chemokine transcytosis across
the endothelium and co-localizes with CCL2 and caveolin-1 in
vesicles [8]. However, direct biochemical and functional evidence
of a caveolin-dependent pathway utilized by DARC are lacking
and the exact mechanisms of DARC mediated chemokine
internalization are unknown. We therefore sought to determine
the mechanisms of DARC-mediated chemokine transcytosis.
Results
As expression of DARC in cultured endothelial cells is rapidly lost,
we stably expressed DARC cDNA into an immortalized human
umbilical vein endothelial cell (HUVEC) line [5,12,13]. We
previously reported that the Duffy-expressing immortalized HUVEC
(DIH) shows saturable binding of
125I-CXCL1/GRO-a with
equilibrium dissociation constant (Kd) of ,5 nM and binds multiple
chemokines with a binding profile consistent with what is reported in
vivo [3,14,15,16,17,18]. Here, we studied the rate of chemokine-
ligand internalization in DIH and mock-transfected immortalized
HUVEC (MIH) cells. We took advantage of the fact that receptor-
ligand interactions on the cell surface are disrupted at low pH and
that internalization is a temperature sensitive process [15,19,20].
MIH cells did not bind or internalize
125I-CXCL1/GRO-a whereas
DIH cells showed rapid
125I-CXCL1 internalization by 15 minutes
with further increases up to 240 minutes (Fig. 1A). However, most of
the ligand could be removed by acid stripping and approximately
40% of bound ligand internalized by 240 minutes (Figure 1B). To
determine whether the modest % of ligand endocytosis was related to
reduced cell integrity over time, we measured cell viability by trypan
blue exclusion and by flow cytometric analysis of 7-aminoactinomy-
cin D (7-AAD)+ cells. Greater than 99% of the cells remained viable
at 240 minutes by trypan blue exclusion, and 95% of the cells
remained 7AAD negative at 240 minutes by flow cytometric analysis
(data not shown). In addition, the internalization rate in DIHcells was
similar to Human Erythroleukemia cells (HEL) which natively
express Duffy antigen (about 30% ligand internalization by
240 minutes) (data not shown).
Because CXCR2 is a high affinity receptor for CXCL1
previously reported to be expressed on endothelial cells [21] and
can potentially influence DARC-dependent CXCL1 endocytosis,
we examined for surface CXCR2 expression on DIH cells by
flow cytometry (Figure 1C-E). Although DIH cells express
surface DARC (Figure 1C), we were unable to confirm
detectable surface CXCR2 expression (Figure 1D). This is in
contrast to peripheral granulocytes which expressed varying
levels of surface CXCR2 under basal conditions (Figure 1E).
Collectively, these data show that
125I-CXCL1 binding and
internalization is dependent upon DARC in DIH cells.
Depletion of cellular cholesterol inhibits DARC-mediated
CXCL1 internalization in endothelial cells
Cholesterol is involved in a number of endocytic pathways,
including the caveolin-dependent pathway, invagination of
clathrin coated pits, membrane ruffling and macropinocytosis
[22,23,24,25,26,27]. We therefore used 2-hydroxypropyl-b-cyclo-
dextrin (HPbCD) to deplete cholesterol from the plasma
membrane in order to determine whether the mechanism of
ligand internalization through DARC was dependent upon
cholesterol. HPbCD treatment significantly attenuated CXCL1
internalization by DIH cells (Figure 2A). The effect of HPbCD
was not due to altered binding of CXCL1 by DIH cells, as we
could displace similar amounts of surface bound
125I-CXCL1 by
excess unlabeled CXCL1 in both HPbCD treated and untreated
cells (Figure 2B). Cholesterol repletion reduced the inhibitory
effect of HPbCD pre-treatment on chemokine endocytosis, with
near complete restoration of chemokine endocytosis to basal
conditions by 4 h (p,0.05) (Figure 2A). These data demonstrate
that DARC-mediated chemokine internalization is dependent
upon cholesterol.
Caveolin-1 is not essential for DARC-mediated ligand
internalization in endothelial cells
As caveolae-mediated endocytosis is disrupted by cholesterol
depletion and caveolin-1 has been shown to co-localize with the
DARC ligands CXCL8 and CCL2 in addition to DARC, we
investigated whether DARC-mediated ligand endocytosis occurs
through a caveolae-dependent pathway [8,12]. We examined
intracellular localization of DARC, caveolin-1, and clathrin in
DIH cells in the presence CCL2 (Figure 3A-E). Consistent with the
findings of Pruenster and colleagues, we show that DARC co-
localized with caveolin-1, a marker of caveolae, but not clathrin by
confocal microscopy in DIH cells (Figure 3A-E) [8]. Similar
findings were obtained when CXCL1 was used as the ligand (data
not shown). By immunoelectron microscopy, we confirm that
caveolin-1 (labeled with 10 nm gold particles, black triangle) co-
localized with DARC (labeled with 5nm gold particle, black
arrows) in DIH cells (Figure 3F, G and H).
To determine whether caveolae are required for DARC-mediated
chemokine internalization, we transfected DIH cells with siRNA
targeted against caveolin-1 and control siRNA. Following transfec-
tion, immunoblotting was performed to confirm knockdown of
caveolin-1. Near complete knockdown of caveolin-1 expression had
no effect on
125I-CXCL1 internalization in DIH cells (Figure 4A–B).
We next examined whether flotillin-1, a protein implicated in
cholesterol-dependent, lipid raft-associated pathways [28], partici-
pates in the endocytosis of chemokine in Duffy expressing endothelial
cells. The depletion of flotillin-1 had no effect on
125I-CXCL1
internalization compared to the cells transfected with control siRNA
(Figure 4C–D). In contrast, knockdown of clathrin significantly
attenuated
125I-transferrin uptake (Figure 4E) but had no effect on
chemokine endocytosis in our model (Figure 4F), confirming that
DARC-mediated chemokine endocytosis does not utilize a clathrin-
dependent pathway. Notably, the majority of transferrin uptake was
rapid occurring by 15 minutes whereas CXCL1 endocytosis
occurred more slowly. The % rate of internalization in our model,
however, for transferrin and CXCL1 was comparable by 120
minutes. Collectively, these findings show that although DARC co-
localizes with caveolin-1, an essential component of caveolae,
caveolin-1 in addition to flotillin-1 and clathrin are dispensable for
DARC-mediated chemokine endocytosis. However, ligand internal-
ization is dependent upon cholestero l ,s u g g e s t i n gt h a ta l t e r n a t i v e
cholesterol-mediated processes such as the macropinocytic pathway
may participate in DARC-mediated ligand internalization in
endothelial cells [23,29].
DARC is located along plasma membrane extensions and
PDGF enhances DARC-mediated chemokine endocytosis
Actin-mediated plasma membrane ruffling is a morphological
change occuring early in several endocytic pathways, including
circular dorsal ruffles (CDRs) that lead to macropinosome
formation [30]. We therefore evaluated the subcelluar localization
of DARC using transmission electron microscopy in resting DIH
cells. DARC was localized to the surface of endothelial cells,
located along plasma membrane extensions with the appearance
of ruffles (Fig. 5). In response to growth factor stimulation, ruffling
occurs within minutes and mediates receptor tyrosine kinase
internalization via the CDRs endocytic pathway [31]. As PDGF
Endothelial DARC Mediated Chemokine Endocytosis
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e29624treatment is a known inducer of ruffling formation [32], and our
findings demonstrate the presence of DARC in membrane
extensions with the appearance of ruffles, we investigated the
effect of PDGF on chemokine internalization in DIH cells.
Confocal imaging confirmed DARC internalization as DARC was
associated with early endosomal antigen (EEA), and to a lesser
extent with lysosomal associated membrane protein (LAMP)
following PDGF stimulation (Figure 6A). PDGF stimulation
consistently increased
125I-CXCL1 internalization in endothelial
cells by 120 minutes (Figure 6B). The effect of PDGF is not due to
upregulation of DARC expression or increased mobilization of
DARC to the surface of the DIH cells (Figure 6C). These data
show that a growth factor mediated pathway enhances CXCL1
internalization in DIH cells.
DARC-mediated CXCL1 internalization does not require
PAK1 and CtBP1 but is dependent upon Dynamin II
expression
It has been shown that P21-activated kinase 1 (PAK1) is
associated with membrane ruffling and it is thought to play an
important regulatory role in macropinocytosis [33]. Phosphoryla-
tion of C-terminal-binding protein-1 (CtBP1) occurs by activated
PAK1 and CtBP1 is essential for the final fission of PAK1
dependent macropinosomes from the plasma membrane [34]. We
therefore examined the role of PAK1 and CtBP1 in CXCL1
internalization by DIH cells. As compared with HeLa cells known
to express abundant PAK1, DIH cells showed minimal PAK1
expression (data not shown). In contrast, CtBP1 expression in DIH
cells was easily detectable under basal conditions (Figure 7A).
Silencing of either PAK1 or CtBP1 did not effect chemokine
internalization by DIH cells (Fig. 7A&B). Based upon these
findings, we concluded that DARC-ligand internalization in DIH
cells is PAK1 and CtBP1 independent.
Dynamin II is a GTPase that promotes fission of the endocytic
membrane and is required for both clathrin and caveolae
mediated endocytosis [35,36]. Dynamin II may also be involved
in regulating actin polymerization and ruffle formation during
macropinocytosis [37]. To assess if dynamin is involved in CXCL1
endocytosis in DIH cells, DIH cells were treated with dynasore, an
inhibitor of dynamin. Dynasore treatment showed inhibition of
internalization of CXCL1 (Figure 8A). Confirming these results,
Figure 1. Duffy antigen mediates CXCL1 binding and endocytosis in DIH cells. MIH cells and DIH cells were incubated with
125I-CXCL1/
GRO-a at the designated time points then were washed with binding buffer or acid wash buffer, as described in Materials and Methods. (A)
Internalized
125I-CXCL1/GRO-a counts in MIH and DIH cells. * p,0.01 MIH cells vs DIH cells, paired t test. (B) Percentage of
125I-CXCL1/GRO-a
internalization in MIH and DIH cells. * p,0.001 MIH cells vs DIH cells, paired t test. Experiments were conducted in triplicates and the mean 6 SEM
from two independent experiments is shown. (C) DIH cells were labeled with anti-Duffy 2C3 Fy6 antibody or isotype mouse IgG1 antibody and
surface expression of Duffy examined by flow cytometry. (D) DIH cells do not show detectable surface CXCR2 expression following immune-labeling
with anti-human CXCR2 or isotype mouse IgG1 antibody. (E) Peripheral leukocytes were isolated from a healthy volunteer and immune-labeled with
anti-human CXCR2 or isotype IgG1 control antibody. Histogram shows gated population of granulocytes expressing CXCR2. Flow cytometric
examination of surface DARC and CXCR2 expression on DIH cells was performed 2 independent times. CXCR2 expression on human peripheral
granulocytes was performed once.
doi:10.1371/journal.pone.0029624.g001
Endothelial DARC Mediated Chemokine Endocytosis
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CXCL1 endocytosis by 120 minutes (Figure 8B). These data
suggest that dynamin II participates in DARC mediated CXCL1
endocytosis.
CXCL1 endocytosis in DIH cells requires actin
polymerization, is amiloride sensitive, and PKC
dependent
Our findings suggest that DARC-mediated CXCL1 endocytosis
is dependent on both cholesterol and Dynamin II and is stimulated
by the growth factor, PDGF. As these molecules have been
previously implicated in macropinocytosis, we examined whether
CXCL1 internalization in DIH cells occurred through this
pathway. Amiloride, an ion exchange inhibitor, is widely used as
an inhibitor of macropinocytosis, as it inhibits macropinocytosis
without a detectable impact on the other known endocytic
pathways [24,38]. Amiloride significantly reduced CXCL1
internalization in DIH cells (Fig. 9A), suggesting that endothelial
CXCL1 internalization occurs through macropinocytosis-like
process.
Membrane ruffling, an essential feature of macropinocytosis,
occurs following actin polymerization [24]. We therefore investi-
gated the effects of actin disruption on CXCL1 internalization
using cytochalasin D, a known inhibitor of actin polymerization
[39]. Cytochalasin D treatment significantly attenuated CXCL1
internalization in DIH cells (Fig. 9B). Because protein kinase C
(PKC) has been shown to be a regulator of macropinocytosis
[40,41], we tested the effect of PKC inhibition on chemokine
internalization in DIH cells. As shown in Fig. 9C, the selective
PKC inhibitor Go ¨6976 inhibited CXCL1 internalization com-
pared to untreated cells. In addition, wortmannin, a PI3K
inhibitor, also inhibited ligand endocytosis by 15 minutes
(p,0.05, data not shown). Taken together, these data suggest a
Figure 2. Cholesterol is required for CXCL1 endocytosis in DIH
cells. (A) DIH cells were pre-treated with 2-hydroxypropyl-b-Cyclodex-
trin prior to incubation with
125I -CXCL1/GRO-a for various time points,
as described in the Materials and Methods. 2-hydroxypropyl-b-
cyclodextrin showed inhibition of chemokine internalization that could
be reversed with cholesterol repletion. * p,0.01, 10 mM 2-hydro-
xypropyl-b-Cyclodextrin treatment vs control, two way ANOVA.
** p,0.05 10 mM 2-hydroxypropyl-b-Cyclodextrin treatment vs reple-
tion with cholesterol, two way ANOVA. (B) DIH cells were pre-treated
with 2-hydroxypropyl-b-Cyclodextrin, prior to the addition of
125I-
CXCL1/GRO-a with or without unlabeled excess CXCL1 for 120 minutes,
as described in the Materials and Methods. Data presented are the
combined results from at least three independent experiments.
doi:10.1371/journal.pone.0029624.g002
Figure 3. Duffy antigen co-localizes with caveolin-1 but not
with clathrin. The DIH cells were stimulated with or without CCL2
100 ng/ml for 120 minutes. Figure A shows a typical single plane
confocal optical section from the lamellipodial region of a cell, with
Panel B focusing at a specific area on the cell outlined by the rectangle
in A. Panel B is then separated into specific color signals to accentuate
the localization status of each protein. Cells are stained for Duffy (Panel
C, blue), caveolin (Panel D, green) and clathrin (Panel E, red). Some
Duffy positive foci colocalize with the caveolin signal (arrows) while no
Duffy signal is seen colocalized with the red clathrin signal(arrowheads).
Figure (F-H), by immuno-EM, caveolin-1 was labeled with 10 nm gold
particle- (.), Duffy antigen was labeled with 5 nm gold particle- (Q),
colocalization between caveolin and Duffy is observed in flask-like
membrane structures- (D).
doi:10.1371/journal.pone.0029624.g003
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with SiRNA targeted against caveolin-1 (A&B), flotillin-1(C&D), clathrin (E, F &G), and control scramble sequence RNA (ScRNA). At 72 hour post-
transfection, endocytosis experiments were performed and cells lysates were analysed by SDS-PAGES and immunoblotted with caveolin-1, clathrin,
flotillin-1 and b-actin antisera. (E) DIH cells transfected with SiCLAC or control SiRNA and were incubated with
125I-transferrin for various time points
then were washed with binding buffer or acid wash buffer, as described in the Materials and Methods. The mean 6 SEM from three independent
experiments is shown.
doi:10.1371/journal.pone.0029624.g004
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CXCL1 internalization in endothelial cells and actin and PKC
mediate this process.
Discussion
The mechanism of DARC-mediated chemokine endocytosis in
endothelial cells remains poorly defined. In this study, we show
several novel findings exploiting the high affinity ligand-receptor
interaction between DARC and the pro-angiogenic CXCL1.
Despite previous reports and our finding showing DARC localized
to caveolae, caveolin-1 is dispensable for DARC-mediated
chemokine endocytosis. In addition, clathrin does not appear
essential for DARC-dependent ligand internalization. Flotillin-1,
an endosomal protein involved in clathrin-independent and
caveolae-independent endocytosis, is also not essential [28]. Our
findings further show that the majority of DARC-chemokine
interactions occur along the surface of DIH cells, located along
plasma membrane extensions, with ligand internalization en-
hanced by PDGF stimulation. The data implicate an alternative
cholesterol-dependent pathway for DARC-ligand internalization
that requires, in part, dynamin II. Moreover, chemokine
endocytosis also requires actin polymerization, is amiloride
sensitive, and PKC-dependent. Although PAK1- and CtBP1-
independent, these lines of evidence support a macropinocytosis-
like process mediating ligand endocytosis by DARC.
Figure 5. Majority of Duffy antigen is present on the surface of
endothelial cells within vesicles and plasma membrane
extensions. Duffy antigen was detected on membrane surfaces by
pre-embedding TEM in DIH cells as described in Materials and Methods.
All panels are imaged from different cells. Duffy antigen (5 nm gold,
arrows) was seen located associated with plasma membrane extensions
and invaginations. These structures are large (.100 nm) and have no
consistent morphology, suggesting they are macropinosomes.
doi:10.1371/journal.pone.0029624.g005
Figure 6. PDGF enhances chemokine internalization in DIH
cells and co-localization with early endosomal antigen. (A) DIH
cells were stimulated with or without PDGF for 10 min, then DARC (red)
and EEA (green) or LAMP (green) co-localization were detected using
confocal imaging. Blue, actin. (B) DIH cells were pretreated with PDGF
50 ng/ml for 10 min prior to endocytosis experiments. By 120 minutes,
PDGF increased DARC-mediated CXCL1 internalization. * p,0.05 PDGF
treatment vs control, paired t test. Cells incubated in the absence of
PDGF served as a control for internalization. Data presented are the
combined results of at least three independent experiments. (C) DIH
cells were pretreated with or without PDGF 50 ng/ml for 10 min prior
to surface staining for DARC as described in the Materials and Methods.
doi:10.1371/journal.pone.0029624.g006
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cells including clathrin-dependent and clathrin-independent
mechanisms. Clathrin-mediated endocytosis has been the most
extensively studied mechanism of chemokine internalization
[42,43,44]. CXCR1 and CXCR2 mediate chemokine endocytosis
through a clathrin, Rab5, dynamin II-dependent process [45]. A
clathrin-dependent pathway is utilized in the internalization of D6,
a seven transmembrane non-signaling chemokine receptor similar
to DARC [46]. Lipid raft and caveolae-mediated pathways of
chemokine internalization have also been described for the
chemokine receptors CCR5 and CXCR4 [42,47,48]. Other
clathrin-independent pathways less commonly utilized by endo-
thelial cells include flotillin-mediated endocytosis, phagocytosis,
clathrin independent cargos/GPI-AP-enriched early endosomal
compartment (CLIC/GEEC) endocytic pathway, and macropi-
nocytosis [28,49,50,51]. Our findings are the first report of
DARC, a seven transmembrane chemokine binding protein,
preferentially utilizing a macropinocytosis-like process for ligand
internalization.
A number of endocytotic pathways require lipid rafts and can be
inhibited by the cholesterol-depleting agent cyclodextrin. We
found that treatment of DIH cells with HPbCD inhibited CXCL1
internalization. Cholesterol repletion following HPbCD treatment
restored chemokine endocytosis, demonstrating that cholesterol is
required for Duffy antigen mediated CXCL1 internalization.
Caveolae-dependent endocytosis requires intact lipid rafts and is
inhibited by depletion of cholesterol. Duffy antigen has previously
been detected in caveolae and colocalizes with the chemokine
CCL2 in caveolin containing vesicles [8,11]. In this study,
however, gene silencing of caveolin-1 expression had no effect
on DARC-mediated chemokine internalization. Although the
findings demonstrate that caveolae is not the dominant mode of
DARC-mediated CXCL1 entry, it remains possible that consti-
tutive re-cycling of DARC in the absence of ligand stimulation
may utilize caveolae. Our findings also do not exclude the
possibility that DARC utilizes multiple redundant pathways for
ligand internalization, and that knockdown of one pathway re-
routes DARC to another pathway.
It is well established that dynamin plays an important role in
both clathrin and caveolae mediated endocytosis [35,36,50].
However, dynamin is also involved in macropinocytosis as it is
localized to pinosome-associated actin comet tails in several types
of cells [52,53]. Here, we demonstrate that inhibitors of dynamin
II and genetic knockdown of dynamin II consistently reduced
chemokine internalization by approximately 50% by 120 minutes,
suggesting that Duffy mediated chemokine internalization is at
least partially dependent on dynamin. Because we were unable to
achieve complete knockdown of dynamin II despite higher molar
concentrations of siRNA used (, 80 nM), we cannot rule out the
possibility that even low expression of dynamin II in endothelial
cells is sufficient to mediate DARC-ligand internalization.
In our model, CXCL1 internalization was inhibited by
amiloride and enhanced by PDGF stimulation, two defining
features of macropinocytosis. Furthermore, inhibition of actin
polymerization and PKC activity consistently reduced chemokine
internalization, supporting the concept that a macropinocytosis-
like process is involved in DARC-mediated chemokine internal-
ization. CtBP1 and PAK1 are involved in the final fission of the
macropinosome from the plasma membrane in macropinocytosis
[24,34]. However, depletion of CtBP1 and PAK1 expression by
Figure 7. CXCL1 endocytosis is CtBP1 and PAK1 independent. DIH cells were transfected with SiRNA targeted against CtBP1 (A) or PAK1 (B)
and control scramble sequence RNA (ScRNA). At 72 hour post-transfection, endocytosis experiment was performed and cells lysates were analysed by
SDS-PAGES and immunoblotted with CtBP1, PAK1 and b-actin antisera. The mean 6 SEM from three independent experiments is shown.
doi:10.1371/journal.pone.0029624.g007
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explanation for the differing results may be that our studies were
conducted in a different cell type from those in previous reports.
The macropinocytosis process is still incompletely characterized,
and unlike receptor-mediated endocytosis and phagocytosis, is not
currently defined by a specific molecular pathway [24]. It is
unclear how many system variations of macropinocytosis there are
in different cell types, as theoretically almost all cell types are
capable of macropinocytosis [54]. Moreover, there are different
kinds of ruffles such as the canonical planar ruffle and circular
ruffles. However, circular ruffles do not appear to require the Rho
family GTPase Ras and Rac1 which are upstream of the target
protein PAK1 [24], and this may account for why we were unable
to block ligand endocytosis by targeting PAK1 or CtBP1.
In summary, our findings provide functional evidence that
DARC-mediated ligand endocytosis is dependent upon a macro-
pinocytosis-like process in endothelial cells and that caveolin-1 is
dispensable for CXCL1 internalization. We also show that the
majority of DARC-ligand interactions occur on the endothelial
surface, supporting the concept that DARC provides a high
affinity scaffold for surface retention of chemokines on endothelial
cells. This is consistent with the findings reported by others that
DARC internalizes and facilitates the transfer of ligand leading to
their apical retention [8]. Recently, DARC has been shown to
exist as homo-dimers and antagonize CCR5 signaling through the
formation of hetero-oligomers [55]. It remains to be seen whether
the process of hetero-oligomer formation diverts DARC to
different endocytic pathways than dimerization.
Materials and Methods
Cell Culture
We previously generated and functionally characterized im-
mortalized Human Umbilical Vein Endothelial Cells (HUVEC)
stably expressing human Duffy cDNA (Accession no. AY167991)
[5]. The immortalized HUVEC line (IVEC) has an indefinite
lifespan in culture but is nontumorgenic. The cell line demon-
strates cobblestone morphology, expresses Factor VIII-related
Antigen, takes up Dil-Ac-LDL, and expresses the integrin subunits
avb3, avb5, a2, a3, b4, and a6, consistent with its endothelial
origin. The Duffy transfected immortalized HUVEC cells are
herein referred to as DIH (Duffy transfected Immortalized
HUVEC) cells. The mock transfected immortalized HUVEC cells
are referred to as MIH (Mock transfected Immortalized HUVEC)
cells. Endothelial cells were maintained in endothelial growth
medium-2 (EGM2) containing 2% fetal calf serum (BioWhittaker,
Walkersville, MD). Upon passage, these cells were repeatedly
tested negative for mycoplasma by PCR.
Immunofluorescence Confocal microscopy
DIH cells were grown in 24 well plates containing 12 mm
round glass coverslips (Thermo-Fisher, Pittsburgh, PA). Cells were
stimulated with 100 ng/mL human recombinant CCL2 (Pepro-
tech, Rocky Hill, NJ) for various time points, and then fixed with
2% paraformaldehyde in PBS, and permeabilized with 0.1%
Triton in PBS for 30 min. Cells were washed in 0.5% BSA in PBS
(PBB), blocked with 2% BSA in PBS for 30 min, and incubated
Figure 8. Silencing of Dynamin II expression partially inhibited chemokine endocytosis. (A) DIH cells were pretreated with dynasore prior
to incubation with
125I-CXCL1/GRO-a for the specified time points, as described in Materials and Methods. Dynasore inhibited CXCL1 internalization in
DIH cells. * p,0.05 dynasore treatment vs control, paired t test. (B) DIH cells were transfected with SiRNA targeted against dynamin II and control
SiRNA (ScRNA). At 72 hour post-transfection, endocytosis experiments were performed and cells lysates were analysed by SDS-PAGES and
immunoblotted with dynamin II and b-actin antisera. The mean 6 SEM from three independent experiments is shown.
doi:10.1371/journal.pone.0029624.g008
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Biosciences, San Jose, CA, IgG1), rabbit anti-caveolin-1 (Abcam,
Cambridge, MA) or mouse anti-clathrin (Abcam, Cambridge,
MA, IgG2b) in PBB at RT for 1 hr. Cells were washed 4 x with
PBB then were stained with goat anti-mouse IgG1-Alexa 647, goat
anti-rabbit IgG Alexa 488 and goat anti-mouse IgG2b-Alexa 564
(all from Invitrogen, Carlsbad, CA) for 1 hr at RT. Omission of
primary antibodies served as controls. Coverslips were mounted to
slides using gelvatol (23g polyvinyl alcohol) 2000, 50 ml glycerol,
0.1% sodium azide to 100 ml PBS). Cells were imaged on a
Fluoview 1000 confocal microscope (Olympus, Center Valley,
PA). Images were taken using a 100x objective using an oil-
immersion 100x objective (N.A.=1.40) digitally zoomed 3x during
image acquisition.
For co-localization studies examining Duffy with early endoso-
mal antigen (EEA) and lysosomal associated membrane protein
(LAMP), DIH cells were grown in 24 well plates containing
12 mm glass coverslips. Cells were stimulated with or without
100 ng/mL human recombinant CXCL1/GRO-a (Peprotech,
Rocky Hill, NJ) or 50 ng/ml PDGF-BB (Millipore, Billerica, MA)
for various time points, and then fixed with 2% paraformaldehyde
in PBS for 1 hr and permeabilized with 0.1% Triton in PBS for
30 min. Cells were washed in 0.5% BSA in PBS (PBB), blocked
with 2% BSA in PBS for 30 min, and incubated with primary
antibodies mouse anti-Duffy 2C3 Fy6, rabbit anti-EEA (1:100
Abcam, Cambridge, MA) and rabbit anti-LAMP (1:100 Abcam,
Cambridge, MA) for 1 hr at RT. Cells were washed 4 x with PBB
then were stained with goat anti-mouse Cy3 (1:1000, Jackson
ImmunoReseach), goat anti-rabbit Alexa 488 (1:500, Invitrogen)
and phalloidin-Alexa 647 (1:250 Invitrogen) for 1 hr at RT. Cells
were processed and imaged for confocal microscopy as described
above.
Transmission electron microscopy
Cryo-sections. DIH cells were fixed in cryofix (2%
paraformaldehyde, 0.01% glutaraldehyde in 0.1 M PBS) and
stored at 4uC for 1 hour. Methods for processing ultrathin
cryosections have been previously described [56]. Prepared
ultrathin sections (70–100 nm) were washed three times with
PBS, then three times with PBS containing 0.5% bovine serum
albumin and 0.15% glycine (PBG buffer) followed by a 30 min
blocking incubation with 5% normal goat serum in PBG. Sections
were labeled with rabbit anti-caveolin 1 and mouse anti-Duffy
2C3 Fy6 in PBG for 1 hr. Sections were subsequently washed four
times in PBG and labeled with goat anti-rabbit (10 nm) or goat
anti-mouse (5 nm) gold conjugated secondary antibodies (GE
Healthcare Biosciences, Piscataway, NJ), each at a dilution of 1:25
for 1 hr. Sections were serially washed in PBG, then PBS, and
fixed in 2.5% glutaraldehyde in PBS for 5 min, followed by PBS
washes and finally in ddH2O. Sections were post-stained in 2%
neutral uranyl acetate, for 7 min, washed three times in ddH2O,
stained 2 min in 4% uranyl acetate, then embedded in 1.25%
methyl cellulose. Labeling was observed on a JEOL JEM 1210
electron microscope (Peabody, MA) at 80 kV.
Pre-Embed ImmunoTEM
DIH monolayers were fixed with 2% paraformaldehyde in PBS
for 1 hr. Cells were washed 3 times in PBS, then 3 times within
PBS supplemented with 0.5% BSA and 0.15% glycine (PBG)
365 min each. Cells were blocked in 20% normal goat serum in
PBG for 40 min then washed once with PBG. Primary antibodies
(mouse anti-Duffy 2C3 Fy6 in PBG for 1 hr) were added to cells in
PBG at a 1:100 dilution and incubated at room temperature for
4 hr. Cells were washed 4 times in PBG then secondary antibody
(goat anti-mouse 5 nm gold conjugate 1:25 in PBG (Jackson
ImmunoResearch Laboratories, West Grove, PA) was added for
3 hr at room temperature. Cells were washed 3 times in PBG, 3
times in PBS, then fixed 1 hr in 2.5% glutaraldehyde in PBS. Cells
were then processed for transmission electron microscopy.
Monolayers were washed in PBS three times then post-fixed in
aqueous 1% osmium tetroxide, 1% potassium ferricyanide for 1
hr. Cells were washed 3 times in PBS then dehydrated through a
30–100% ethanol series then several changes of Polybed 812
Figure 9. Addition of amiloride, inhibition of actin polymeri-
zation, or PKC inhibition decreased CXCL1 internalization in
DIH cells. DIH cells were pre-treated with various inhibitors prior to
incubation with
125I-CXCL1/GRO-a for the specified time points, as
described in Materials and Methods. (A) Amiloride significantly inhibited
DARC-mediated CXCL1 internalization in DIH cells. * p,0.05 amiloride
treatment vs control, paired t test. (B) Actin polymerization inhibitor
cytochalasin D decreased CXCL1 internalization in DIH cells. * p,0.05
cytochalasin D treatment vs control, paired t test. (C) PKC inhibitor
Go ¨6976 also showed inhibition of CXCL1 internalization. * p,0.05
Go ¨6976 treatment vs control, paired t test. Shown is the mean 6 SEM
from three experiments.
doi:10.1371/journal.pone.0029624.g009
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embedded in by inverting Polybed 812-filled BEEM capsules on
top of the cells. Blocks were cured overnight at 37uC, then cured
for two days at 65uC. Monolayers were pulled off the tissue culture
plates and ultrathin cross sections (70 nm) of the cells were
obtained on a Riechart Ultracut E microtome, post-stained in 4%
uranyl acetate for 10 min and 1% lead citrate for 7 min. Sections
were viewed on a JEOL JEM 1011 transmission electron
microscope (JEOL, Peobody MA) at 80 KV. Images were taken
using a side-mount AMT 2k digital camera (Advanced Microscopy
Techniques, Danvers, MA).
Flow cytometry
DIH cells were pretreated with or without PDGF (Millipore,
Billerica, MA) (50 ng/ml) for 10 minutes, then the cells were
washed and resuspended in PBS containg 2% FBS. Then the cells
were stained with primary antibodies mouse anti-Duffy 2C3 Fy6
(BD Biosciences, San Jose, CA) or Isotype control IgG1 antibody
(R&D systems, Minneapolis, MN) for 30 minutes at 4uC. After
incubation with secondary antibody anti-mouse IgG-PE for
30 minutes, Flow cytometric analysis was performed on a BD
Biosciences FACSCalibur.
In experiments pertaining to surface CXCR2 expression, we
obtained whole blood from a healthy volunteer following written
informed consent. The Institutional Review Board of University
of Pittsburgh approved the studies. The cell pellet was obtained
following centrifugation of whole blood at 500 g for 5 minutes.
Red blood cells (RBC) were lysed using a commercially available
RBC lysis buffer (eBiosciences, San Diego, CA). The cell pellet
was washed with PBS x 3, and labeled with either anti-human
CXCR2 (BD Biosciences, San Jose, CA) or mouse IgG1 isotype
control antibody (BD Biosciences, San Jose, CA) for 30 minutes
DIH cells were stained with mouse anti-Duffy 2C3 Fy6, anti
human CXCR2 (BD Biosciences, San Jose, CA) or mouse IgG1
isotype control antibody (BD Biosciences, San Jose, CA) for
30 minutes. Samples were analyzed by flow cytometry as stated
above.
SiRNA transfection
DIH cells were transfected with siRNA (80 nM) directed against
Caveolin-1(CAV), Clathrin heavy chain (CLAC), Dynamin II
(DYN II), Flotillin-1 (FLOT), C-terminal-binding protein-1
(CtBP1) and P21-activated kinase 1 (PAK1), using HiperFect
(Qiagen, Valencia, CA) according to the manufacturer’s instruc-
tions. The transfection efficiency was determined by the protein
expression by immunoblotting with the corresponding antibodies
72 hours later, and internalizations assays were performed using
nonsilencing SiRNA as controls. All SiRNAs were purchased from
Dharmacon and all these SiRNAs are pools of four SiRNA
duplexes (smartpools).
Western blot analysis
Rabbit anti-caveolin-1 (Abcam, Cambridge, MA), mouse anti-
clathrin (BD Transduction Laboratories, San Jose, CA), mouse
anti-dynamin II (BD Transduction Laboratories, San Jose, CA),
mouse anti-flotillin-1 (BD Transduction Laboratories, San Jose,
CA), mouse anti-CtBP1 (BD Transduction Laboratories, San Jose,
CA), rabbit anti-PAK1 (Cell signaling Technology Inc, Boston,
MA) were used for immunoblotting. Proteins were resolved by
SDS-PAGE under reducing conditions, transferred to a nitrocel-
lulose membrane, and blocked with 5% nonfat dried milk in TBS
containing 0.05% Tween 20 for 1 h. Immunoblotting was
performed by incubating membranes in blocking solution
containing primary antibodies at 4uC overnight. Following
extensive washing with TBS containing 0.05% Tween 20, the
membranes were incubated with horseradish peroxidase-conju-
gated secondary antibodies (Cell Signaling Technology Inc,
Boston, MA) for 1 hour at room temperature. An enhanced
chemiluminescence detection kit (Thermo Scientific, Rockford, IL)
was used to visualize bound antibody.
Receptor Ligand Internalization
Methods for radioligand internalization were modified from
Peiper et al. [15]. All chemical inhibitors were purchased from
Sigma (St Louis, MO) unless otherwise indicated. 2-hydroxypro-
pyl-b-Cyclodextrin (10 mM), dynasore (50 mM), amiloride
(3 mM), cytochalasin D (2.5 mM), Go ¨6976 (1 mM; Calbiochem,
Gibbstown, NJ) and PDGF-BB (Millipore, Billerica, MA) (50 ng/
ml) were used for endocytosis studies. Binding buffer consisted of
RPMI 1640 containing 0.2% BSA, and 12.5 mM HEPES buffer,
pH 7.4. Acid wash buffer consisted of binding buffer at pH 3.0.
DIH or MIH cells (0.2610
6 cells) were incubated with 0.2 nM
125I-CXCL1/GRO-a (Perkin Elmer, Waltham, MA) or 0.075 mCi
125I-Transferrin (Perkin Elmer, Waltham, MA) at 37uCo r4 uC.
Non labeled excess CXCL1/GRO-a (R&D SYSTEMS, Minne-
apolis, MN) (1 mM) was added in some experiments. At given time
points, the reaction was terminated by centrifugation to separate
the cell pellet from supernatant. The pellet was washed twice with
either binding buffer or acid wash buffer, followed by a final
centrifugation step. The acid-wash step displaced surface bound
125I-CXCL1/GRO-a. Radioactivity was measured in counts per
minute (cpm) using a gamma counter. The %
125I-CXCL1/GRO-
a internalized was determined by measuring the average activity of
acid-washed wells at 37uC as a percentage of the average activity
of non-acid washed wells at 37uC, as previously utilized by others
[46,57]. Average activity of wells incubated at 37uC but acid
washed (washed with binding buffer, pH 3) reflected internalized
ligand. Average activity of wells incubated at 37uC but not acid
washed (washed with binding buffer, pH 7.4) reflected total
binding. In order to determine the efficiency of this method, wells
reflecting total surface binding (incubated at 4uC, not acid washed)
were washed with excess unlabeled ligand (1 mM) and compared
to the findings of wells incubated at 4uC and acid washed. Initial
results showed that wells incubated at 4uC and acid washed very
efficiently removed surface bound ligand. Cholesterol repletion
studies have been previously described [58]. Cells were pretreated
with 2-hydroxypropyl-b-Cyclodextrin (10 mM) for 30 min fol-
lowed by incubation in the presence or absence of water soluble
cholesterol (400 mg/ml, Sigma, St. Louis, MO).
125I-CXCL1
internalization was examined in cells at designated time points as
described above.
Statistics
Student’s paired t-test was conducted to compare treatment
versus control groups at each time point. For cyclodextrin and
cholesterol repletion studies, a two-way analysis of variance
(ANOVA) was conducted to compare multiple treatment groups
and control across various time points. Statistical analysis was
performed using GraphPad Prism5 (GraphPad software, La Jolla,
CA).
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